Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Cash from Operations: 2009-2025

Historic Cash from Operations for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $66.2 million.

  • National Healthcare's Cash from Operations rose 9351.89% to $66.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $207.5 million, marking a year-over-year increase of 9923.77%. This contributed to the annual value of $107.3 million for FY2024, which is 351.84% down from last year.
  • Per National Healthcare's latest filing, its Cash from Operations stood at $66.2 million for Q3 2025, which was up 9351.89% from $62.8 million recorded in Q2 2025.
  • In the past 5 years, National Healthcare's Cash from Operations registered a high of $66.2 million during Q3 2025, and its lowest value of -$27.5 million during Q1 2022.
  • In the last 5 years, National Healthcare's Cash from Operations had a median value of $25.7 million in 2023 and averaged $24.1 million.
  • Per our database at Business Quant, National Healthcare's Cash from Operations tumbled by 31810.31% in 2022 and then soared by 173404.15% in 2023.
  • Over the past 5 years, National Healthcare's Cash from Operations (Quarter) stood at $15.5 million in 2021, then decreased by 23.12% to $11.9 million in 2022, then skyrocketed by 115.63% to $25.7 million in 2023, then crashed by 50.3% to $12.8 million in 2024, then surged by 417.61% to $66.2 million in 2025.
  • Its Cash from Operations stands at $66.2 million for Q3 2025, versus $62.8 million for Q2 2025 and $39.3 million for Q1 2025.